Bitter melon (Momordica Charantia): A review of efficacy and safety

American Journal of Health-System Pharmacy

Volumn 60, Issue 4, 2003, Pages 356-359

  Basch, Ethan ^a   Gabardi, Steven ^b,c   Ulbricht, Catherine ^a  

^a Natural Standard   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Alternative medicine; Antidiabetic agents; Diabetes mellitus; Drug interactions; Momordica charantia; Plants; Toxicity

Indexed keywords

ALKALINE PHOSPHATASE; CHLORPROPAMIDE; GAMMA GLUTAMYLTRANSFERASE; MOMORDICA CHARANTIA EXTRACT; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE; PLANT EXTRACT;

ALTERNATIVE MEDICINE; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CONVULSION; DIABETES MELLITUS; DRUG EFFICACY; DRUG SAFETY; FAVISM; HEADACHE; HUMAN; HYPOGLYCEMIC COMA; INFERTILITY; INSULIN LIKE ACTIVITY; LACTATION; LIVER DYSFUNCTION; PREGNANCY; PRIORITY JOURNAL; REVIEW; ANIMAL; DRUG INTERACTION; MOMORDICA CHARANTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYTOTHERAPY;

ANIMALS; DIABETES MELLITUS, TYPE 2; DRUG INTERACTIONS; HUMANS; MOMORDICA CHARANTIA; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 0038283005     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.4.356     Document Type: Review

References (30)

1. Bourinbaiar AS, Lee-Huang S. The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against herpes simplex virus in vitro. Biochem Biophys Res Commun. 1996; 219:923-9.
2. Lee-Huang S, Huang PL, Chen HC et al. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. Gene. 1995; 161:151-6.
3. Lee-Huang S, Huang PL, Huang PL et al. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31. Proc Natl Acad Sci U S A. 1995; 92:8818-22.
4. Lee-Huang S, Huang PL, Sun Y et al. Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30. Anticancer Res. 2000; 20(2A):653-9.
5. Ng TB, Wong CM, Li WW et al. Insulin-like molecules in Momordica charantia seeds. J Ethnopharmacol. 1986; 15:107-17.
6. Ng TB, Wong CM, Li WW et al. Isolation and characterization of a galactose binding lectin with insulinomimetic activities from the seeds of the bitter gourd Momordica charantia (family Cucurbitaceae). Int J Pept Protein Res. 1986; 28(2):163-72.
7. Wong CM, Yeung HW, Ng TB. Screening of Trichosanthes kirilowii, Momordica charantia and Cucurbita maxima (family Cucurbitaceae) for compounds with antilipolytic activity. J Ethnopharmacol. 1985; 13:313-21.
8. Shibib BA, Khan LA, Rahman R. Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem J. 1993; 292(pt. 1):267-70.
9. Welihinda J, Arvidson G, Gylfe E et al. The insulin-releasing activity of the tropical plant Momordica charantia. Acta Biol Med Ger. 1982; 41:1229-40.
10. Day C, Cartwright T, Provost J et al. Hypoglycaemic effect of Momordica charantia extracts. Planta Med. 1990; 56:426-9.
11. Sarkar S, Pranava M, Marita R. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol Res. 1996; 33(1):1-4.
12. Khanna P, Jain SC, Panagariya A et al. Hypoglycemic activity of polypeptide-p from a plant source. J Nat Prod. 1981; 44:648-55.
13. Marles R, Farnsworth N. Antidiabetic plants and their active constituents: an update. Phytomedicine. 1997; 2:137-89.
14. Wang YX, Jacob J, Wingfield PT et al. Anti-HIV and anti-tumor protein MAP30, a 30 kDa single-strand type-I RIP, shares similar secondary structure and beta-sheet topology with the A chain of ricin, a type-II RIP. Protein Sci. 2000; 9(1):138-44.
15. Baldwa VS, Bhandra CM, Pangaria A et al. Clinical trials in patients with diabetes mellitus of an insulin-like compound obtained from plant source. Upsala J Med Sci. 1977; 82:39-41.
16. Leatherdale BA, Panesar RK, Singh G et al. Improvement in glucose tolerance due to Momordica charantia (karela). Br Med J (Clin Res Ed). 1981; 282:1823-4.
17. Srivastava Y. Antidiabetic and adaptogenic properties of Momordica charantia extract: an experimental and clinical evaluation. Phytother Res. 1993; 7:285-9.
18. Welihinda J, Karunanayake EH, Sheriff MH et al. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol. 1986; 17:277-82.
19. Hulin A, Wavelet M, Desbordes JM. Intoxication aigue par Momordica charantia (sorrossi). A propos de deux cas. Sem Hop. 1988; 64:2847-8.
20. Raman A, Lau C. Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae). Phytomedicine. 1996; 2:349-62.
21. Stepka W, Wilson KE, Madge GE. Antifertility investigation on Momordica. Lloydia. 1974; 37:645.
22. Dixit VP, Khanna P, Bhargava SK. Effects of Momordica charantia L. fruit extract on the testicular function of dog. Planta Med. 1978; 34:280-6.
23. Schreiber CA, Wan L, Sun Y et al. The antiviral agents, MAP30 and GAP31, are not toxic to human spermatozoa and may be useful in preventing the sexual transmission of human immunodeficiency virus type 1. Fertil Steril. 1999; 72:686-90.
24. Dutta PK, Chakravarty AK, Chowdhury US et al. Vicine, a favism-inducing toxin from Momordica charantia Linn. seeds. Indian J Chem. 1981; 20B:669-71.
25. Tennekoon KH, Jeevathayaparan S, Angunawala P et al. Effect of Momordica charantia on key hepatic enzymes. J Ethnopharmacol. 1994; 44:93-7.
26. Aguwa CN, Mittal GC. Abortifacient effects of the roots of Momordica angustisepala. J Ethnopharmacol. 1983; 7:169-73.
27. Chan WY, Tam PP, Yeung HW. The termination of early pregnancy in the mouse by beta-momorcharin. Contraception. 1984; 29(1):91-100.
28. Leung SO, Yeung HW, Leung KN. The immunosuppressive activities of two abortifacient proteins isolated from the seeds of bitter melon (Momordica charantia). Immunopharmacology. 1987; 13:159-71.
29. Aslam M, Stockley IH. Interaction between curry ingredient (karela) and drug (chlorpropamide). Lancet. 1979; 1:607. Letter.
30. Kulkarni RD, Gaitonde BB. Potentiation of tolbutamide action by jasad bhasma and karela (Momordica charantia). Indian J Med Res. 1962; 50:715-9.